Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-067715
Filing Date
2021-12-02
Accepted
2021-12-02 20:42:20
Documents
1
Period of Report
2021-12-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7761
  Complete submission text file 0001209191-21-067715.txt   9218
Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 (215) 921-7600
AMICUS THERAPEUTICS, INC. (Issuer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AMICUS THERAPEUTICS, INC. 1 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address
Campbell Bradley L (Reporting) CIK: 0001400971 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33497 | Film No.: 211468441